Clinical Differences Between Solifenacin and Tolterodine Anne K. MongiuLori B. Lerner ReviewPaper 01 December 2010 Pages: 1 - 6
Current Use of Botulinum A Toxin in Overactive Bladder Management Sara SpettelCharles WelliverElise De ReviewPaper 08 January 2011 Pages: 7 - 12
Conservative Management and Behavioral Modifications for Overactive Bladder Aqsa KhanJennifer T. Anger ReviewPaper 05 January 2011 Pages: 13 - 19
Topical Pharmacotherapy for Overactive Bladder Doreen E. Chung ReviewPaper 21 December 2010 Pages: 20 - 24
Expanding the Role of Neuromodulation for Overactive Bladder: New Indications and Alternatives to Delivery Ngoc-Bich LeJa-Hong Kim ReviewPaper Open access 25 November 2010 Pages: 25 - 30
Augmentation Cystoplasty Gjanjé L. SmithKathleen C. Kobashi ReviewPaper 16 November 2010 Pages: 31 - 36
Treatment of Neurogenic Voiding Dysfunction: An Update Laura G. StansellAriana L. SmithWilliam I. Jaffe ReviewPaper 18 December 2010 Pages: 37 - 44
Future Directions in Overactive Bladder Treatment Melissa R. Kaufman ReviewPaper 06 November 2010 Pages: 45 - 50
Pharmacodynamics of Overactive Bladder Drugs: Shifting the Curve David R. StaskinRachna K. ChawlaMichael G. Oefelein ReviewPaper 08 January 2011 Pages: 51 - 63